Study | Treatment group | Genotype | Number of animals | Sex | Age range (weeks) | Weight range at start of procedure (g) |
---|---|---|---|---|---|---|
I.p. injection of LPS (group 1) | Control | WT | 4 | Male | 17–18 | 21–28 |
Treatment | WT | 4 | Male | 17–18 | 20–25 | |
Control | P2ry6−/− | 4 | Male | 18–20 | 22–29 | |
Treatment | P2ry6−/− | 4 | Male | 18–20 | 20–26 | |
I.p. injection of LPS (group 2) | Control | WT | 4 | Male | 20–26 | 32–36 |
Treatment | WT | 4 | Male | 20–26 | 34–38 | |
Control | P2ry6−/− | 4 | Male | 20–25 | 28–35 | |
Treatment | P2ry6−/− | 4 | Male | 20–25 | 29–35 |